Deximune (ciclosporin): Reviews and patient testimonials

Deximune 100 mg soft capsule

Transplantation Indications

Solid Organ Transplantation

Prevention of graft rejection following solid organ transplantation.

Treatment of transplant rejection in patients previously receiving other immunosuppressive agents.

Bone Marrow Transplantation

Prevention of graft rejection following allogeneic bone marrow and stem cell transplantation.

Prevention or treatment of graft-versus-host disease (GVHD).

Non-Transplantation Indications

Endogenous uveitis

Treatment of sight-threatening intermediate or posterior uveitis of non-infectious aetiology in patients in whom conventional therapy has failed or caused unacceptable side effects.

Treatment of Behçet uveitis with repeated inflammatory attacks involving the retina in patients without neurological manifestations.

Psoriasis

Deximune Capsules are indicated in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate.

Atopic Dermatitis

Deximune Capsules are indicated in patients with severe atopic dermatitis when systemic therapy is required.

Rheumatoid Arthritis

Deximune Capsules are indicated for the treatment of severe, active rheumatoid arthritis.

Nephrotic Syndrome

Steroid-dependent and steroid-resistant nephrotic syndrome due to primary glomerular diseases such as minimal change nephropathy, focal segmental glomerulosclerosis or membranous glomerulonephritis.

Deximune Capsules can be used to induce remissions and for maintenance remissions. It can also be used to maintain steroid-induced remission, allowing withdrawal of steroids.

Deximune 25 mg soft capsules

Transplantation Indications

Solid Organ Transplantation

Prevention of graft rejection following solid organ transplantation.

Treatment of transplant cellular rejection in patients previously receiving other immunosuppressive agents.

Bone Marrow Transplantation

Prevention of graft rejection following allogeneic bone marrow and stem cell transplantation.

Prevention or treatment of graft-versus-host disease (GVHD).

Non-Transplantation Indications

Endogenous uveitis

Treatment of sight-threatening intermediate or posterior uveitis of non-infectious aetiology in patients in whom conventional therapy has failed or caused unacceptable side effects.

Treatment of Behçet uveitis with repeated inflammatory attacks involving the retina in patients without neurological manifestations.

Psoriasis

Deximune Capsules are indicated in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate.

Atopic Dermatitis

Deximune Capsules are indicated in patients with severe atopic dermatitis when systemic therapy is required.

Rheumatoid Arthritis

Deximune Capsules are indicated for the treatment of severe, active rheumatoid arthritis.

Nephrotic Syndrome

Steroid-dependent and steroid-resistant nephrotic syndrome due to primary glomerular diseases such as minimal change nephropathy, focal segmental glomerulosclerosis or membranous glomerulonephritis.

Deximune Capsules can be used to induce remissions and for maintenance remissions. It can also be used to maintain steroid-induced remission, allowing withdrawal of steroids.

Deximune 50 mg soft capsules

Transplantation Indications

Solid Organ Transplantation

Prevention of graft rejection following solid organ transplantation.

Treatment of transplant cellularrejection in patients previously receiving other immunosuppressive agents.

Bone Marrow Transplantation

Prevention of graft rejection following allogeneic bone marrow and stem cell transplantation.

Prevention or treatment of graft-versus-host disease (GVHD).

Non-Transplantation Indications

Endogenous uveitis

Treatment of sight-threatening intermediate or posterior uveitis of non-infectious aetiology in patients in whom conventional therapy has failed or caused unacceptable side effects.

Treatment of Behçet uveitis with repeated inflammatory attacks involving the retina in patients without neurological manifestations.

Psoriasis

Deximune Capsules are indicated in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate.

Atopic Dermatitis

Deximune Capsules are indicated in patients with severe atopic dermatitis iwhen systemic therapy is required.

Rheumatoid Arthritis

Deximune Capsules are indicated for the treatment of severe, active rheumatoid arthritis.

Nephrotic Syndrome

Steroid-dependent and steroid-resistant nephrotic syndrome due to primary glomerular diseases such as minimal change nephropathy, focal segmental glomerulosclerosis or membranous glomerulonephritis.

Deximune Capsules can be used to induce remissions and for maintenance remissions. It can also be used to maintain steroid-induced remission, allowing withdrawal of steroids.